Macquarie Group LTD Nektar Therapeutics Transaction History

Macquarie Group LTD

$87.4 Billion
Q1 2024

A detailed history of Macquarie Group LTD transactions in Nektar Therapeutics stock. As of the latest transaction made, Macquarie Group LTD holds 256,385 shares of NKTR stock, worth $299,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

256,385

Previous 256,385 -0.0%

Holding current value

$299,970

Previous $143,000 66.43%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$2.03 - $4.28 $5,188 - $10,939	-2,556 Reduced 0.99%	256,385 $579,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $11,880 - $20,087	-3,908 Reduced 1.49%	258,941 $841,000
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $8,711 - $28,729	-2,094 Reduced 0.79%	262,849 $1.42 Million
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $34,779 - $50,133	-2,661 Reduced 0.99%	264,943 $4.76 Million
Q2 2021 Aug 13, 2021	BUY	$16.52 - $20.4 $60,380 - $74,562	3,655 Added 1.38%	267,604 $4.59 Million

Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $30,685 - $47,177	-1,853 Reduced 0.7%	263,949 $5.28 Million
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $11,613 - $17,353	700 Added 0.26%	265,802 $4.41 Million
Q2 2020 Aug 11, 2020	BUY	$16.86 - $23.44 $18,832 - $26,182	1,117 Added 0.42%	265,102 $6.14 Million
Q1 2020 May 15, 2020	BUY	$14.47 - $27.96 $1.32 Million - $2.56 Million	91,385 Added 52.95%	263,985 $4.71 Million
Q4 2019 Feb 14, 2020	BUY	$15.87 - $23.12 $34,914 - $50,864	2,200 Added 1.29%	172,600 $3.73 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $133,300 - $156,090	4,300 Added 2.59%	170,400 $6.06 Million
Q4 2018 Feb 15, 2019	SELL	$30.43 - $56.65 $27,387 - $50,985	-900 Reduced 0.54%	166,100 $5.46 Million
Q3 2018 Nov 15, 2018	BUY	$46.46 - $68.49 $92,920 - $136,980	2,000 Added 1.21%	167,000 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $6.92 Million - $15.6 Million	149,522 Added 966.03%	165,000 $8.06 Million
Q1 2018 May 11, 2018	SELL	$57.4 - $108.44 $1 Million - $1.89 Million	-17,468 Reduced 53.02%	15,478 $1.65 Million
Q4 2017 Feb 15, 2018	BUY	$23.02 - $60.5 $758,416 - $1.99 Million	32,946	32,946 $1.97 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Nektar Therapeutics Transaction History